ANGLE PLC CEO Announces Breakthrough in CellKeep Technology
ANGLE PLC CEO Andrew Newland announces breakthrough in CellKeep technology and optimized antibodies for cell phenotyping, significantly improving reliability and efficiency of diagnostic processes.
The breakthrough in CellKeep technology and optimized antibodies for cell phenotyping will significantly impact medical laboratories, improving the reliability and efficiency of diagnostic processes. This news is important for anyone in the medical research and diagnostic industry, as it represents a major step forward in addressing longstanding issues, ultimately leading to better healthcare outcomes.
